Facebook
Instagram
Linkedin
Pinterest
Twitter
Youtube
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Tag: Daniel Tassé
DBV Announces Promising 2-Year Results from Ongoing Viaskin “Peanut Patch” Toddler...
News Wire ~ 3rd Party Press Release
-
2023/11/10
81.3% of subjects who completed the oral food challenge reached an eliciting dose of ≥1,000 mg after 24 months of treatment.
DBV Outlines Path to Regulatory Approval of Viaskin Peanut Patch
Dave Bloom
-
2023/04/21
Are Viaskin therapies finally on the horizon?
FDA Removes Hold Allowing DBV’s Pivotal Phase 3 Peanut Patch Trial...
Dave Bloom
-
2022/12/26
The phase 3 trial of the modified Viaskin Peanut patch has been cleared for commencement.
FDA Issues Partial Hold on DBV Viaskin Peanut Patch Trial
Dave Bloom
-
2022/09/22
Another delay for the long-awaited therapy.
DBV Begins Phase 3 Study of Redesigned Viaskin Peanut Patch in...
Dave Bloom
-
2022/09/14
Viaskin is testing a new version of their patch designed to address the FDA's concerns.
DBV Announces Positive Topline Results from Phase 3 Trial of Viaskin...
News Wire ~ 3rd Party Press Release
-
2022/06/08
Viaskin Peanut demonstrated a statistically significant treatment effect with 67.0% of subjects meeting the treatment responder criteria after 12 months.
Viaskin Peanut Patch Therapy Delayed Further as DBV Readies Another Phase...
Dave Bloom
-
2021/12/22
The patch therapy remains in regulatory limbo.
FDA Wants More Viaskin Peanut Data Resulting in Further Approval Delays
Dave Bloom
-
2021/10/27
Delays mount pushing trials of modified patch.
DBV, Developers of Patch Therapies for Allergies to Peanuts, Milk and...
Dave Bloom
-
2021/01/08
The company announced they would be laying off 200 employees in Q1.
FDA Denies Approval of Viaskin Peanut “Patch” Therapy
Dave Bloom
-
2020/08/04
The FDA raised concerns that adhesion of the patch would affect the efficacy of the therapy.
1
2
Page 1 of 2